rg-101 (for viral effect targeting mir-122) (Regulus Therapeutics)
90
Structured Review
Regulus Therapeutics
rg-101 (for viral effect targeting mir-122)
Rg 101 (For Viral Effect Targeting Mir 122), supplied by Regulus Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rg-101+(for+viral+effect+targeting+mir-122)/rg+101/pmc10385075-92-46-61
Average 90 stars, based on 1 article reviews
Rg 101 (For Viral Effect Targeting Mir 122), supplied by Regulus Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rg-101+(for+viral+effect+targeting+mir-122)/rg+101/pmc10385075-92-46-61
Average 90 stars, based on 1 article reviews
rg-101 (for viral effect targeting mir-122) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity Article Snippet: MRX34 (for cancer treatment targeting miR-34), Cobomarsen (MRG-106) (for cutaneous T-cell lymphoma treatment targeting miR-155), MRG-107 (for amyotrophic lateral sclerosis treatment targeting miR-155), MRG-110 (for ischemia treatment targeting miR-92a), and Remlarsen (MRG-201) (for fibrosis treatment targeting miR-29) are under development by miRagen therapeutics, Colorado, US, while RG-101 (for viral effect targeting miR-122) and |